Search Results

You are looking at 1 - 2 of 2 items for :

  • Author or Editor: David E. Anderson x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective—To determine in vitro effects of PBSS, milk, and bacteria-contaminated milk (BCM; contaminated by Streptococcus agalactiae) on properties of 3 synthetic absorbable suture materials.

Sample Population—3 types of synthetic absorbable suture materials (poliglecaprone 25, polyglycolic acid, and polydioxanone).

Procedures—Suture materials were tested to determine breaking strength and elasticity before (day 0) and after incubation in 3 media (PBSS, milk, and BCM) for 7, 14, and 21 days. A loop of suture material was elongated at a rate of 60 mm/min until it reached the breaking point. Tensile properties were statistically analyzed among media and incubation times.

Results—Incubation in milk and BCM significantly decreased breaking strength and elasticity of poliglecaprone 25, compared with results for incubation in PBSS. Incubation in BCM significantly decreased tensile properties of polyglycolic acid suture, compared with results for incubation in PBSS and milk. After incubation for 21 days, tensile properties of polydioxanone did not differ significantly among the media but were significantly decreased from values on day 0.

Conclusions and Clinical Relevance—On the basis of this study, poliglecaprone 25 is an inappropriate suture material for use in teat surgery. Polyglycolic acid suture should be avoided in teats of cattle with mastitis. Of the suture materials tested, polydioxanone was best suited for use in teat surgery, as determined on the basis of material testing after incubation in milk, even when the milk was contaminated with bacteria.

Full access
in American Journal of Veterinary Research

Abstract

Objective—To determine elution characteristics of bone morphogenetic protein (BMP)-2 from a polycaprolactone coating applied to orthopedic implants and determine effects of this coating on osseointegration.

Animals—6 sheep.

Procedures—An in vitro study was conducted to determine BMP-2 elution from polycaprolactone-coated implants. An in vivo study was conducted to determine the effects on osseointegration when the polycaprolactone with BMP-2 coating was applied to bone screws. Osseointegration was assessed via radiography, measurement of peak removal torque and bone mineral density, and histomorphometric analysis. Physiologic response was assessed by measuring serum bone-specific alkaline phosphatase activity and uptake of bone markers.

Results—Mean ± SD elution on day 1 of the in vitro study was 263 ± 152 pg/d, which then maintained a plateau at 59.8 ± 29.1 pg/d. Mean peak removal torque for screws coated with polycalprolactone and BMP-2 (0.91 ± 0.65 dN·m) and screws coated with polycaprolactone alone (0.97 ± 1.30 dN·m) did not differ significantly from that for the control screws (2.34 ± 1.62 dN·m). Mean bone mineral densities were 0.535 ± 0.060 g/cm2, 0.596 ± 0.093 g/cm2, and 0.524 ± 0.142 g/cm2 for the polycaprolactone–BMP-2–coated, polycaprolactone-coated, and control screws, respectively, and did not differ significantly among groups. Histologically, bone was in closer apposition to the implant with the control screws than with either of the coated screws.

Conclusions and Clinical Relevance—BMP-2 within the polycaprolactone coating did not stimulate osteogenesis. The polycaprolactone coating appeared to cause a barrier effect that prevented formation of new bone. A longer period or use of another carrier polymer may result in increased osseointegration.

Full access
in American Journal of Veterinary Research